MK-0431/ONO-5435 Phase III Clinical Study - Glimepiride add-on Study for Patients with Type 2 Diabetes Mellitus
Phase 3
- Conditions
- Type 2 Diabetes Mellitus
- Registration Number
- JPRN-jRCT2080220288
- Lead Sponsor
- ONO PHARMACEUTICAL CO.,LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
The target population is the outpatients >=20 years of age with type 2 diabetes mellitus (male and female) who have inadequate glycemic control on diet/exercise therapy and glimepiride as monotherapy.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy, Safety
- Secondary Outcome Measures
Name Time Method